Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT03117192 |
Date of registration:
|
31/03/2017 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Zinc Supplementation on Cellular Immunity in Thalassemia Major
|
Scientific title:
|
Zinc Supplementation on Cellular Immunity in Thalassemia Major |
Date of first enrolment:
|
September 1, 2013 |
Target sample size:
|
58 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03117192 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Care Provider, Investigator).
|
Phase:
|
Phase 4
|
|
Countries of recruitment
|
Indonesia
| | | | | | | |
Contacts
|
Name:
|
Teny T Sari, M.D., PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Faculty of Medicine University of Indonesia |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Thalassemia major patients
- Age > 12 years
- Agreed to participate and signed the informed consent
- No other comorbidity beside thalassemia
Exclusion Criteria:
- HIV positive patients
- Those in steroid medication
Age minimum:
12 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Thalassemia
|
Immunosuppression
|
Splenectomy; Status
|
Intervention(s)
|
Drug: Zinc Sulfate
|
Drug: Sucrose Syrup
|
Primary Outcome(s)
|
Patient's T-lymphocyte count
[Time Frame: 12 weeks]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|